Phase Ib study of oral panobinostat (LBH589) plus lenalidomide (LEN) plus dexamethasone (DEX) in patients (Pts) with relapsed (Rel) or Rel and refractory (Ref) multiple myeloma (MM).
暂无分享,去创建一个
S. Lonial | T. Facon | J. San-Miguel | M. Mateos | B. Bengoudifa | A. Spencer | J. Rubia | K. Taylor | P. Bourquelot | K. Hazell